Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Capital Leases (2019 - 2025)

Marimed (MRMD) has disclosed Capital Leases for 7 consecutive years, with $2.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Capital Leases fell 2.95% to $2.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.2 million, a 2.95% decrease, with the full-year FY2024 number at $1.9 million, down 10.0% from a year prior.
  • Capital Leases was $2.2 million for Q3 2025 at Marimed, down from $2.2 million in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $2.7 million in Q2 2024 to a low of $22000.0 in Q4 2021.
  • A 5-year average of $1.2 million and a median of $1.5 million in 2023 define the central range for Capital Leases.
  • Peak YoY movement for Capital Leases: crashed 50.55% in 2021, then surged 1995.45% in 2022.
  • Marimed's Capital Leases stood at $22000.0 in 2021, then soared by 1995.45% to $461000.0 in 2022, then skyrocketed by 364.21% to $2.1 million in 2023, then decreased by 10.0% to $1.9 million in 2024, then rose by 12.82% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Capital Leases are $2.2 million (Q3 2025), $2.2 million (Q2 2025), and $1.9 million (Q1 2025).